Fagan Associates, Inc. Edwards Lifesciences Corp Transaction History
Fagan Associates, Inc.
- $575 Million
- Q1 2025
A detailed history of Fagan Associates, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fagan Associates, Inc. holds 3,092 shares of EW stock, worth $226,550. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,092
Previous 3,892
20.55%
Holding current value
$226,550
Previous $288,000
22.22%
% of portfolio
0.04%
Previous 0.05%
Shares
14 transactions
Others Institutions Holding EW
# of Institutions
1,376Shares Held
486MCall Options Held
2.77MPut Options Held
2.05M-
Vanguard Group Inc Valley Forge, PA69.2MShares$5.07 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.73 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$2.13 Billion0.42% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.89 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.61 Billion0.12% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $45.3B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...